Analysis of HFE and TFR2 mutations in selected blood donors with biochemical parameters of iron overload
- PMID: 12681966
Analysis of HFE and TFR2 mutations in selected blood donors with biochemical parameters of iron overload
Abstract
Background and objectives: Hereditary hemochromatosis is a recessive condition characterized by iron accumulation in several organs, followed by organ damage and failure. The disorder is prevalently due to C282Y and H63D mutations in the HFE gene, but additional HFE and TFR2 mutations have been reported. Early iron overload may be assessed by biochemical parameters such as increased transferrin saturation and serum ferritin.
Design and methods: Taking advantage of the collection of 178 DNA samples selected for increased transferrin saturation (>50% in males and >45% in females) from a previous large scale screening of Italian blood donors, we simultaneously assessed the presence of 14 hemochromatosis-associated molecular defects (11 of HFE and 3 of TFR2) by a reverse hybridization-based strip assay.
Results: In the series studied the overall C282Y allele frequency was 9% and that of the H63D and S65C was 22.2% and 1.4%, respectively. One rare HFE allele (E168Q), but no TFR2 mutation was detected. When checked at a second examination, transferrin saturation was significantly higher in C282Y homozygotes, H63D/ C282Y compound heterozygotes and H63D homozygotes as compared to wild-type subjects (p<0.05).
Interpretation and conclusions: Our results confirm previous findings on C282Y and H63D mutations in Italy, show that the C282Y allele frequency is enriched in samples selected for altered iron parameters, and that a few rare genotypes are present in Northern Italy. None of the known TFR2 mutations was identified in this series confirming the preliminary indication of their rare occurrence. Subjects with hemochromatosis-associated genotypes show a persistently higher mean transferrin saturation than do those with wild type genotypes.
Similar articles
-
Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience.Haematologica. 2004 Oct;89(10):1161-7. Haematologica. 2004. PMID: 15477198
-
Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis.Blood Cells Mol Dis. 2001 Jan-Feb;27(1):290-3. doi: 10.1006/bcmd.2001.0382. Blood Cells Mol Dis. 2001. PMID: 11358390
-
Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation.Hematol J. 2003;4(6):436-40. doi: 10.1038/sj.thj.6200324. Hematol J. 2003. PMID: 14671617
-
Contribution of different HFE genotypes to iron overload disease: a pooled analysis.Genet Med. 2000 Sep-Oct;2(5):271-7. doi: 10.1097/00125817-200009000-00001. Genet Med. 2000. PMID: 11399207 Review.
-
HFE Mutations as risk factors in disease.Best Pract Res Clin Haematol. 2002 Jun;15(2):295-314. Best Pract Res Clin Haematol. 2002. PMID: 12401309 Review.
Cited by
-
Recent advances in understanding haemochromatosis: a transition state.J Med Genet. 2004 Oct;41(10):721-30. doi: 10.1136/jmg.2004.020644. J Med Genet. 2004. PMID: 15466004 Free PMC article. Review.